Net Income (Loss) Attributable to Parent in USD of Teladoc Health, Inc. from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Teladoc Health, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2013 to Q3 2025.
  • Teladoc Health, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$49.5M, a 48.8% decline year-over-year.
  • Teladoc Health, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$224M, a 77.2% increase year-over-year.
  • Teladoc Health, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$1B, a 354% decline from 2023.
  • Teladoc Health, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$220M, a 98.4% increase from 2022.
  • Teladoc Health, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.7B, a 3086% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Teladoc Health, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$224M -$49.5M -$16.2M -48.8% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 -$207M -$32.7M +$805M +96.1% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025
Q1 2025 -$1.01B -$93M -$11.1M -13.6% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 -$1B -$48.4M -$19.5M -67.6% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025
Q3 2024 -$982M -$33.3M +$23.8M +41.7% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 -$1.01B -$838M -$772M -1185% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025
Q1 2024 -$233M -$81.9M -$12.7M -18.3% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 -$220M -$28.9M +$3.78B +99.2% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 -$4B -$57.1M +$16.4M +22.3% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 -$4.02B -$65.2M +$3.04B +97.9% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024
Q1 2023 -$7.05B -$69.2M +$6.61B +99% 01 Jan 2023 31 Mar 2023 10-Q 26 Apr 2024
Q4 2022 -$13.7B -$3.81B -$3.8B -34584% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025
Q3 2022 -$9.86B -$73.5M +$10.9M +12.9% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023
Q2 2022 -$9.87B -$3.1B -$2.97B -2218% 01 Apr 2022 30 Jun 2022 10-Q 28 Jul 2023
Q1 2022 -$6.9B -$6.67B -$6.47B -3243% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 -$429M -$11M +$383M +97.2% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2024
Q3 2021 -$812M -$84.3M -$48.5M -135% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 -$763M -$134M -$108M -421% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 -$655M -$200M -$170M -574% 01 Jan 2021 31 Mar 2021 10-Q 02 May 2022
Q4 2020 -$485M -$394M -$375M -1969% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023
Q3 2020 -$110M -$35.9M -$15.5M -76.4% 01 Jul 2020 30 Sep 2020 10-Q 01 Nov 2021
Q2 2020 -$94.7M -$25.7M +$3.64M +12.4% 01 Apr 2020 30 Jun 2020 10-Q 02 Aug 2021
Q1 2020 -$98.3M -$29.6M +$547K +1.81% 01 Jan 2020 31 Mar 2020 10-Q 02 Aug 2021
Q4 2019 -$98.9M -$19M +$5.84M +23.5% 01 Oct 2019 31 Dec 2019 10-K 26 Feb 2020
Q3 2019 -$105M -$20.3M +$2.92M +12.5% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 -$108M -$29.3M -$4.25M -16.9% 01 Apr 2019 30 Jun 2019 10-Q 06 Nov 2020
Q1 2019 -$103M -$30.2M -$6.29M -26.4% 01 Jan 2019 31 Mar 2019 10-Q 06 Nov 2020
Q4 2018 -$97.1M -$24.9M +$19.5M +43.9% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2020
Q3 2018 -$117M -$23.3M +$8.07M +25.7% 01 Jul 2018 30 Sep 2018 10-K 26 Feb 2020
Q2 2018 -$125M -$25.1M -$9.66M -62.7% 01 Apr 2018 30 Jun 2018 10-K 26 Feb 2020
Q1 2018 -$115M -$23.9M -$8.21M -52.4% 01 Jan 2018 31 Mar 2018 10-K 26 Feb 2020
Q4 2017 -$107M -$44.4M -$30.1M -211% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2019
Q3 2017 -$76.7M -$31.3M -$1.56M -5.23% 01 Jul 2017 30 Sep 2017 10-K 27 Feb 2019
Q2 2017 -$75.1M -$15.4M -$536K -3.6% 01 Apr 2017 30 Jun 2017 10-K 27 Feb 2019
Q1 2017 -$74.6M -$15.7M -$350K -2.29% 01 Jan 2017 31 Mar 2017 10-K 27 Feb 2019
Q4 2016 -$74.2M -$14.3M +$746K +4.97% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2018
Q3 2016 -$75M -$29.8M -$16.5M -125% 01 Jul 2016 30 Sep 2016 10-K 27 Feb 2018
Q2 2016 -$58.4M -$14.9M +$2.19M +12.8% 01 Apr 2016 30 Jun 2016 10-K 27 Feb 2018
Q1 2016 -$60.6M -$15.3M -$2.6M -20.5% 01 Jan 2016 31 Mar 2016 10-K 27 Feb 2018
Q4 2015 -$58M -$15M 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018
Q3 2015 -$13.2M -$8.72M -192% 01 Jul 2015 30 Sep 2015 10-Q 27 Oct 2016
Q2 2015 -$17.1M -$13.9M -433% 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016
Q1 2015 -$12.7M 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q3 2014 -$4.53M 01 Jul 2014 30 Sep 2014 10-Q 02 Nov 2015
Q2 2014 -$3.2M 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015

Teladoc Health, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1B -$781M -354% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025
2023 -$220M +$13.4B +98.4% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 -$13.7B -$13.2B -3086% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025
2021 -$429M +$56.3M +11.6% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024
2020 -$485M -$386M -391% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
2019 -$98.9M -$1.78M -1.83% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 -$97.1M +$9.7M +9.08% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 -$107M -$32.6M -43.9% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 -$74.2M -$16.2M -27.9% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
2015 -$58M -$41M -241% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
2014 -$17M -$11M -183% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017
2013 -$6.02M 01 Jan 2013 31 Dec 2013 10-K 03 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.